Finance of America Companies Inc. 31738L206 US31738L2060 05/15/2026 To approve the compensation of the named executive officers of the Company SECTION 14A SAY-ON-PAY VOTES 688766 0 FOR 688766 FOR Celcuity Inc. 15102K100 US15102K1007 05/14/2026 To ratify named Executive Officers' Compensation SECTION 14A SAY-ON-PAY VOTES 1357 0 FOR 1357 FOR Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 To ratify named Executive Officers' Compensation SECTION 14A SAY-ON-PAY VOTES 61445 0 AGAINST 61445 AGAINST Piper Sandler Companies 724078209 US7240782091 05/20/2026 An advisory (non-binding) vote to approve the compensation of the officers disclosed in the enclosed proxy statement SECTION 14A SAY-ON-PAY VOTES 2428 0 AGAINST 2428 AGAINST CVC Capital Partners plc G2716N103 JE00BRX98089 05/12/2026 To receive and approve, on an advisory basis, the report of the Company's remuneration committee (the Remuneration Committee) for the financial year ended 31 December 2025 (the Remuneration Report) as set out on pages 75 to 81 of the Annual Report and Accounts SECTION 14A SAY-ON-PAY VOTES 97753181 0 FOR 97753181 FOR Vodafone Group Plc 92857W308 US92857W3088 07/29/2025 To approve the Annual Report on Remuneration contained in the Remuneration Report of the Board for the year ended 31 March 2025 SECTION 14A SAY-ON-PAY VOTES 5371 0 FOR 5371 FOR Cardinal Health, Inc 14149Y108 US14149Y1082 11/05/2025 To approve, on a non-binding advisory basis, the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES 1718 0 FOR 1718 FOR Repare Therapeutics Inc. 760273102 US7602731025 01/16/2026 An ordinary resolution to approve, on an advisory and non-binding basis, the compensation to be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Arrangement. SECTION 14A SAY-ON-PAY VOTES 3443659 0 FOR 3443659 FOR Aquestive Therapeutics, Inc. 03843E104 US03843E1047 06/10/2026 To approve the compensation of the Company's named executives SECTION 14A SAY-ON-PAY VOTES 1207932 0 FOR 1207932 FOR Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 To approve the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 1814764 0 FOR 1814764 FOR Compass Pathways PLC 20451W101 US20451W1018 05/27/2026 To approve the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 904504 0 FOR 904504 FOR Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To approve the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 510000 0 FOR 510000 FOR EyePoint Pharmaceuticals, Inc. 30233G209 US30233G2093 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement SECTION 14A SAY-ON-PAY VOTES 912594 0 FOR 912594 FOR Larimar Therapeutics, Inc. 517125100 US5171251003 05/19/2026 Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 7120007 0 FOR 7120007 FOR Larimar Therapeutics, Inc. 517125100 US5171251003 05/19/2026 Approval, on an Advisory Basis, of the Preferred Frequency of Future Advisory Votes on the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 7120007 0 1 YEAR 7120007 FOR Marker Therapeutics, Inc. 57055L206 US57055L2060 05/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement SECTION 14A SAY-ON-PAY VOTES 554250 0 FOR 554250 FOR ORIC Pharmaceuticals, Inc 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, executive compensation SECTION 14A SAY-ON-PAY VOTES 225000 0 FOR 225000 FOR ORIC Pharmaceuticals, Inc 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation SECTION 14A SAY-ON-PAY VOTES 225000 0 1 YEAR 225000 FOR Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation SECTION 14A SAY-ON-PAY VOTES 2969199 0 FOR 2969199 FOR Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 31259 0 FOR 31259 FOR Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 31259 0 1 YEAR 31259 FOR Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 302638 0 FOR 302638 FOR